Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
enGene Holdings Inc. - Common Stock
(NQ:
ENGN
)
7.660
+0.030 (+0.39%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about enGene Holdings Inc. - Common Stock
enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
November 05, 2024
From
enGene Holdings Inc.
Via
Business Wire
enGene Announces $60 Million Private Placement Financing
October 25, 2024
From
enGene Holdings Inc.
Via
Business Wire
enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
October 22, 2024
From
enGene Holdings Inc.
Via
Business Wire
Lumira Ventures Portfolio Company enGene (Nasdaq:ENGN) Debuts as Publicly Traded Genetic Medicines Company
November 02, 2023
Via
ACCESSWIRE
enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer
October 21, 2024
From
enGene Holdings Inc.
Via
Business Wire
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 01, 2024
From
enGene Holdings Inc.
Via
Business Wire
Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort
September 26, 2024
From
enGene Holdings Inc.
Via
Business Wire
enGene Reports Third Quarter 2024 Financial Results and Provides a Business Update
September 10, 2024
From
enGene Holdings Inc.
Via
Business Wire
enGene to Participate in Upcoming Investor Conferences
August 28, 2024
From
enGene Holdings Inc.
Via
Business Wire
enGene Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
July 24, 2024
From
enGene Holdings Inc.
Via
Business Wire
enGene Announces Appointment of Ron Cooper as Chief Executive Officer
July 24, 2024
From
enGene Holdings Inc.
Via
Business Wire
NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors
July 18, 2024
From
NewAmsterdam Pharma N.V.
Via
GlobeNewswire
enGene Reports Second Quarter 2024 Financial Results and Provides a Business Update
June 14, 2024
From
enGene Holdings Inc.
Via
Business Wire
enGene to Present at the Jefferies Global Healthcare Conference
May 29, 2024
From
enGene Holdings Inc.
Via
Business Wire
enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors
May 15, 2024
From
enGene Holdings Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.